Select Page

Press Releases

Sign up to get full access to all our latest Press Releases

Rapid Dose Announces Proposed Equity Private Placement Financing

January 20, 2024


BURLINGTON, Ontario – January 19, 2024 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that it plans to complete an equity private placement financing (the “Financing”) for up to $7,000,000 of gross proceeds, consisting of up to 41,176,470 units (the...

Rapid Dose Closes Fourth Tranche of Private Placement Financing and Announces Proposed Debt Settlement

December 22, 2023


BURLINGTON, Ontario – December 22, 2023 Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) is pleased to announce that it has closed on $855,000 in a fourth tranche of its previously announced private placement financing (the “Financing”) bringing the total amount invested to...

Rapid Dose Therapeutics Corp. Provides Update on Private Placement

December 6, 2023


BURLINGTON, Ontario – December 6, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that further to its press release dated November 14, 2023 announcing a third tranche closing of $500,000, thereby bringing the total amount invested to approximately $2,300,000,...

Rapid Dose Therapeutics Corp. Engages European Consulting Firm

November 22, 2023


BURLINGTON, Ontario – November 22, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) is pleased to announce that it has retained Profinnotiv AG (the “Consultant”) to provide the Company with investor and public relations services in the European market, including brand...

Rapid Dose Therapeutics Corp. Closes Third Tranche of Private Placement Financing

November 14, 2023


BURLINGTON, Ontario – November 14, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) is pleased to announce that it has closed on $500,000 in a third tranche of its previously announced private placement financing (the “Financing”) bringing the total amount invested...

Rapid Dose Therapeutics Corp. Provides Update on Private Placement

October 25, 2023


BURLINGTON, Ontario – October 24, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that further to its press release dated September 22, 2023 announcing a second tranche closing of approximately $300,000, thereby bringing the total amount invested to approximately...

‘Game changer’ A revolution in vaccines, medication and drugs happening in Burlington

October 19, 2023


As we celebrate Small Business Week, Effie J. Triantafilopoulos, MPP for Oakville North -Burlington, toured the Rapid Dose Therapeutics facility in Burlington on Oct. 12 to discuss their innovative Oral Thin Film (OTF) delivery platform and highlight the company’s recent achievements. “You’ve got seniors who...

Payment in Shares for Fees and Interest on Secured Debt 

October 10, 2023


BURLINGTON, Ontario – October 5, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) announced today that as contemplated in the secured convertible notes (the “Notes”) previously issued on its placement financing (the “Financing”), the Company intends to issue common shares (“Common...

Closing of Second Tranche of Private Placement Financing, Amendment to Terms of Secured Debt and Director Change

September 22, 2023


Corporate Update BURLINGTON, Ontario – September 22, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) is pleased to announce that it has closed on $310,000 in a second tranche of its previously announced private placement financing (the “Financing”) bringing the total...

Rapid Dose Provides Update on Private Placement

September 14, 2023


BURLINGTON, Ontario – September 14 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that further to its press release dated July 24, 2023 announcing a first tranche closing of approximately $1,500,000, the Company has received an extension from the...

1 2 3 4 5 6 7 8 9 10 11 12 13 15